South West Sydney Clinical Campuses

Kaazan P; Li T; Seow W; Bednarz J; Pipicella JL; Krishnaprasad K; Ng W; Williams A-J; Connor SJ; Andrews JM, 2021, 'Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease', JGH OPEN, vol. 5, pp. 1063 - 1070, http://dx.doi.org/10.1002/jgh3.12631

Gu B; De Gregorio M; Pipicella JL; Vande Casteele N; Andrews JM; Begun J; Connell W; D'Souza B; Gholamrezaei A; Hart A; Liew D; Radford-Smith G; Rimola J; Sutherland T; Toong C; Woods R; Wu Y; Xuan W; Williams AJ; Ng W; Ding NS; Connor S, 2021, 'Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol', BMJ open, vol. 11, http://dx.doi.org/10.1136/bmjopen-2020-043921

Wu Y; Wen A; Selvanderan SP; Xuan W; Andrews JM; Koo JH; Williams AJ; Ng W; Connor S, 2021, 'Management Decisions in Crohn's Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels', Crohn's and Colitis 360, vol. 3, http://dx.doi.org/10.1093/crocol/otab042

Wu Y; Lin B; Thilakanathan C; Lehmann P; Xuan W; Mohsen W; Toong C; Williams AJ; Ng W; Connor S, 2021, 'Therapeutic drug monitoring in inflammatory bowel disease reduces unnecessary use of infliximab with substantial associated cost-savings', Internal Medicine Journal, vol. 51, pp. 739 - 745, http://dx.doi.org/10.1111/imj.14644

Williams AJ, 2021, 'Advanced therapies in inflammatory bowel disease: Special considerations', Journal of Gastroenterology and Hepatology (Australia), vol. 36, pp. 22 - 24, http://dx.doi.org/10.1111/jgh.15454

Mohsen W; Williams AJ; Wark G; Sechi A; Koo JH; Xuan W; Bassan M; Ng W; Connor S, 2021, 'Prospective single-blinded single-center randomized controlled trial of Prep Kit-C and Moviprep: Does underlying inflammatory bowel disease impact tolerability and efficacy?', World Journal of Gastroenterology, vol. 27, pp. 1090 - 1100, http://dx.doi.org/10.3748/wjg.v27.i11.1090

Williams AJ; Paramsothy R; Wu N; Ghaly S; Leach S; Paramsothy S; Corte C; O'Brien C; Burke C; Wark G; Samocha-Bonet D; Lambert K; Ahlenstiel G; Wasinger V; Dutt S; Pavli P; Grimm M; Lemberg D; Connor S; Leong R; Hold G, 2021, 'Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study', BMJ open, vol. 11, pp. e042493, http://dx.doi.org/10.1136/bmjopen-2020-042493

Wang G; Karimi N; Willmann L; Descallar J; O'Connor K; Pipicella JL; Leung Y; Williams A-J; Huang V, 2021, 'Sa069 A NOVEL DECISION AID IMPROVES KNOWLEDGE AND QUALITY OF PREGNANCY-RELATED DECISION-MAKING IN WOMEN WITH INFLAMMATORY BOWEL DISEASE', Gastroenterology, vol. 160, pp. S - 407, http://dx.doi.org/10.1016/s0016-5085(21)01682-6

Karimi N; Moore AR; Lukin A; Kanazaki R; Williams AJ; Connor S, 2020, 'Clinical communication in inflammatory bowel disease: A systematic literature review protocol', BMJ Open, vol. 10, pp. e039503, http://dx.doi.org/10.1136/bmjopen-2020-039503

Gu B; Venkatesh K; Williams A-J; Ng W; Corte C; Simon G; Xuan W; Paramsothy S; Connor SJ, 2020, 'Sa1891 HIGHER INFLIXIMAB AND ADALIMUMAB TROUGH LEVELS ARE ASSOCIATED WITH FISTULA HEALING IN PATIENTS WITH FISTULISING PERIANAL CROHN'S DISEASE', Gastroenterology, vol. 158, http://dx.doi.org/10.1016/s0016-5085(20)31850-3

Bressler B; Greenup A-J; Bassel M; Stein D; Soni M; Radulescu G; Neish C; Khalid JM; Demuth D, 2018, 'P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn’s disease patients (EVOLVE) in Canada: Interim results', Journal of Crohn's and Colitis, vol. 12, pp. S382 - S382, http://dx.doi.org/10.1093/ecco-jcc/jjx180.673

Chiu K; Greenup A-J; Bressler B; Schaeffer D; Xiong W, 2018, 'Su1699 IMPROVING AGREEMENT IN THE HISTOLOGIC GRADE OF ACTIVITY IN ULCERATIVE COLITIS', Gastrointestinal Endoscopy, vol. 87, pp. AB375 - AB375, http://dx.doi.org/10.1016/j.gie.2018.04.1811

Greenup A; Rosenfeld G; Bressler B, 2017, 'P625 Ustekinumab use in Crohn's disease: effectiveness of dose escalation', Journal of Crohn's and Colitis, vol. 11, pp. S400 - S400, http://dx.doi.org/10.1093/ecco-jcc/jjx002.749

Greenup A; Rosenfeld G; Bressler B, 2017, 'P597 Ustekinumab use in Crohn's disease: a tertiary centre experience', Journal of Crohn's and Colitis, vol. 11, pp. S384 - S385, http://dx.doi.org/10.1093/ecco-jcc/jjx002.721

Greenup A-J; Rosenfeld G; Leung Y, 2017, 'Fecal Calprotectin in Pregnancy.', Inflamm Bowel Dis, vol. 23, pp. E49 - E50, http://dx.doi.org/10.1097/MIB.0000000000001241

Greenup A-J; Rosenfeld G; Bressler B, 2017, 'Ustekinumab use in Crohn's disease: a Canadian tertiary care centre experience.', Scand J Gastroenterol, vol. 52, pp. 1354 - 1359, http://dx.doi.org/10.1080/00365521.2017.1373847

Rosenfeld G; Greenup A-J; Round A; Takach O; Halparin L; Saadeddin A; Ho JK; Lee T; Enns R; Bressler B, 2016, 'FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.', World J Gastroenterol, vol. 22, pp. 8211 - 8218, http://dx.doi.org/10.3748/wjg.v22.i36.8211

Thompson KD; Connor SJ; Walls DM; Gollins J; Stewart SK; Bewtra M; Baumblatt GL; Holubar SD; Greenup AJ; Sechi A; Girgis A; Rubin DT; Siegel CA, 2016, 'Patients with ulcerative colitis are more concerned about complications of their disease than side effects of medications', Inflammatory Bowel Diseases, vol. 22, pp. 940 - 947, http://dx.doi.org/10.1097/MIB.0000000000000740

Greenup A-J; Rosenfeld G; Bressler B, 2016, 'Ustekinumab Use in Crohnʼs Disease: Real-Life Canadian Experience', American Journal of Gastroenterology, vol. 111, pp. S334 - S335, http://dx.doi.org/10.14309/00000434-201610001-00745

Greenup A-J; Bressler B; Rosenfeld G, 2016, 'Medical Imaging in Small Bowel Crohn's Disease-Computer Tomography Enterography, Magnetic Resonance Enterography, and Ultrasound: "Which One Is the Best for What?".', Inflamm Bowel Dis, vol. 22, pp. 1246 - 1261, http://dx.doi.org/10.1097/MIB.0000000000000727

Greenup AJ; Tan PK; Nguyen V; Glass A; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Jackson K; Locarnini SA; Levy MT, 2015, 'Corrigendum to "efficacy and safety of tenofovir disoproxil fumarate (TDF) in pregnancy to prevent perinatal transmission of hepatitis B virus" (J Hepatol (2014) 61:502-507)', Journal of Hepatology, vol. 63, pp. 1054, http://dx.doi.org/10.1016/j.jhep.2015.07.017

Kumbhari V; Greenup A; Abi-Hanna D, 2014, 'Gastrointestinal: Endoscopic treatment of an infected pancreatic pseudocyst post-insertion of a covered self-expandable metal stent (CSEMS)', Journal of Gastroenterology and Hepatology (Australia), vol. 29, pp. 1851, http://dx.doi.org/10.1111/jgh.12764

Nguyen V; Tan PK; Greenup AJ; Glass A; Davison S; Samarasinghe D; Holdaway S; Strasser SI; Chatterjee U; Jackson K; Locarnini SA; Levy MT, 2014, 'Anti-viral therapy for prevention of perinatal HBV transmission: Extending therapy beyond birth does not protect against post-partum flare', Alimentary Pharmacology and Therapeutics, vol. 39, pp. 1225 - 1234, http://dx.doi.org/10.1111/apt.12726

Greenup AJ; Pokorny CS, 2014, 'Eosinophilic oesophagitis: Diagnosis and management', Medicine Today, vol. 15, pp. 29 - 33

Greenup AJ; Tan PK; Nguyen V; Glass A; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Jackson K; Locarnini SA; Levy MT, 2014, 'Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus', Journal of Hepatology, vol. 61, pp. 502 - 507, http://dx.doi.org/10.1016/j.jhep.2014.04.038

Siegel CA; Thompson KD; Walls D; Connor SJ; Stewart SK; Bewtra M; Rubin DT; Baumblatt GL; Holubar SD; Greenup A-J; Sechi A; Girgis A; Gollins J, 2014, 'Sa1122 Patients With Ulcerative Colitis Are More Concerned About Complications of Their Disease Than Side Effects of Medications', Gastroenterology, vol. 146, pp. S - 205, http://dx.doi.org/10.1016/s0016-5085(14)60726-5

Thompson KD; Connor SJ; Walls D; Gollins J; Stewart SK; Bewtra M; Baumblatt GL; Holubar SD; Greenup A-J; Sechi A; Girgis A; Rubin DT; Siegel CA, 2014, 'Sa1123 What Patients Want to Know When Making Decisions About Their Treatment for Ulcerative Colitis: A Mixed Methods Approach Using Affect Trace Technology', Gastroenterology, vol. 146, http://dx.doi.org/10.1016/s0016-5085(14)60727-7

Greenup A-J; Chatterjee U; Smith LE; Levy M, 2012, 'The hepatitis B bear: novel patient orientated information enhances patient understanding of the phases of hepatitis B', JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, vol. 27, pp. 166 - 166, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000308642600340&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Greenup A-J; Tan PK; Vi N; Glass AL; Lord HL; Chatterjee U; Davison S; Smith LE; Holdaway S; Samarasinghe D; Locarnini S; Levy M, 2013, 'Efficacy and safety of tenofovir in pregnancy to prevent Mother to Baby transmission of HBV', in HEPATOLOGY, WILEY-BLACKWELL, Washington, DC, pp. 625A - 625A, presented at 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, DC, 01 November 2013 - 05 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330252203048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Vi N; Tan PK; Greenup A-J; Glass AL; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Locarnini S; Levy M, 2013, 'Prolonging antiviral therapy after pregnancy for prevention of perinatal HBV transmission does not abrogate post-partum flares', in HEPATOLOGY, WILEY-BLACKWELL, Washington, DC, pp. 641A - 642A, presented at 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, Washington, DC, 01 November 2013 - 05 November 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000330252203080&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nguyen VI; Tan PK; Greenup A; Glass A; Davison S; Chatterjee U; Holdaway S; Samarasinghe D; Locarnini SA; Levy MT, 2013, 'Prolonging antiviral therapy after pregnancy for prevention of perinatal HBV transmission does not abrogate post-partum flares', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 69 - 69, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900146&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Greenup A-J; Koo J; Sechi A; Levy M; Ng W; Connor S, 2013, 'Prospective single-blinded single-centre randomized controlled trial comparing moviprep with prepkit c using standard split preparation protocol in patients for elective colonoscopy', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 19 - 20, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Greenup A-J; Tan PK; Nguyen V; Glass A; Lord H; Chatterjee U; Davison S; Smith L; Ayres A; Holdaway S; Samarasinghe D; Locarnini S; Levy M, 2013, 'Efficacy and safety of tenofovir in pregnancy to prevent mother to baby transmission of hepatitis B virus', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, pp. 151 - 152, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000324106900320&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Greenup A-J; Chatterjee U; Smith LE; Levy M, 2012, 'The Hepatitis B Bear: Novel patient orientated information enhances patient understanding of the phases of Hepatitis B', in HEPATOLOGY, WILEY-BLACKWELL, Boston, MA, pp. 355A - 355A, presented at 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), Boston, MA, 09 November 2012 - 13 November 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000310955601333&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1